1,507
Views
41
CrossRef citations to date
0
Altmetric
Research Article

Characterization and antimicrobial application of biosynthesized gold and silver nanoparticles by using Microbacterium resistens

, , , , , , & show all
Pages 1714-1721 | Received 15 Jul 2015, Accepted 27 Aug 2015, Published online: 23 Nov 2015

Figures & data

Figure 1. Reaction mixture after incubation period containing gold nanoparticles (a), control (b) and containing silver nanoparticles (c). UV–Vis spectra of the reaction mixture of gold nanoparticles (d), reaction mixture of silver nanoparticles (e).

Figure 1. Reaction mixture after incubation period containing gold nanoparticles (a), control (b) and containing silver nanoparticles (c). UV–Vis spectra of the reaction mixture of gold nanoparticles (d), reaction mixture of silver nanoparticles (e).

Figure 2. TEM image of gold nanoparticles at 10 nm (a), at 20 nm (b), silver nanoparticles at 10 nm (c), at 20 nm (d).

Figure 2. TEM image of gold nanoparticles at 10 nm (a), at 20 nm (b), silver nanoparticles at 10 nm (c), at 20 nm (d).

Figure 3. EDX spectrum of gold nanoparticles (a), elemental mapping: electron micrograph region of gold nanoparticles (b), distribution of gold element (c). EDX spectrum of silver nanoparticles (d), elemental mapping: electron micrograph region of silver nanoparticles (e), distribution of silver element (f).

Figure 3. EDX spectrum of gold nanoparticles (a), elemental mapping: electron micrograph region of gold nanoparticles (b), distribution of gold element (c). EDX spectrum of silver nanoparticles (d), elemental mapping: electron micrograph region of silver nanoparticles (e), distribution of silver element (f).

Figure 4. Particles size distribution of gold nanoparticles according to intensity (a), number (b), and volume (c); and silver nanoparticles according to intensity (d), number (e), and volume (f).

Figure 4. Particles size distribution of gold nanoparticles according to intensity (a), number (b), and volume (c); and silver nanoparticles according to intensity (d), number (e), and volume (f).

Figure 5. Antimicrobial activity of nanoparticles in comparison with antibiotics against V. parahaemolyticus, S. enterica, S. aureus, B.anthracis, B.cereus, E. coli, and C. albicans. Note: P10, penicillin G 10 μg/disk; OL15, oleandomycin 15 μg/disk; MY15, lincomycin 15 μg/disk; cycloheximide, 10 μg/disk; AuNPs, gold nanoparticles, 30 μl (100 mg/l); AgNPs, silver nanoparticles, 30 μl (100 mg/l).

Figure 5. Antimicrobial activity of nanoparticles in comparison with antibiotics against V. parahaemolyticus, S. enterica, S. aureus, B.anthracis, B.cereus, E. coli, and C. albicans. Note: P10, penicillin G 10 μg/disk; OL15, oleandomycin 15 μg/disk; MY15, lincomycin 15 μg/disk; cycloheximide, 10 μg/disk; AuNPs, gold nanoparticles, 30 μl (100 mg/l); AgNPs, silver nanoparticles, 30 μl (100 mg/l).

Table I. Antimicrobial activity of nanoparticles against V. parahaemolyticus, S. enterica, S. aureus, B. anthracis, B. cereus, E. coli, and C. albicans.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.